Novo Nordisk’s Obesity Drug Activities Break UK Rules Again
Pharmacists’ Prescribing Of Saxenda Returns To Spotlight
The company has been found in breach of the UK code once again for its work with pharmacists, although this time Novo Nordisk has escaped the heaviest censure.
